QUOTE AND NEWS
Benzinga  May 31  Comment 
In a report published Friday, Jefferies analyst Brandon Couillard assumed coverage on Luminex (NASDAQ: LMNX) with a Hold rating, and raised the price target from $17.00 to $20.00. In the report, Jefferies noted, “Cautious on long-term...
StreetInsider.com  May 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Luminex+%28LMNX%29%2C+Merck+KGaA+Unit+Extend+Global+Supply%2C+Distribution+Agreement/8373045.html for the full story.
TheStreet.com  May 21  Comment 
span.style4 {font-size: 10px; font-weight: bold; } span.style5 {font-size: 10px} By Jonathan Moreland, founder of Insider Insights and author of Profit From Legal Insider Trading. NEW YORK (TheStreet) -- It is a victory for...
StreetInsider.com  Apr 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Luminex+Corp+%28LMNX%29+Tops+Q1+EPS+by+12c/8286492.html for the full story.
Benzinga  Apr 15  Comment 
Luminex Corporation (NASDAQ: LMNX) today announced it has received U.S. FDA clearance of its MAGPIX instrument, with its xTAG Gastrointestinal Pathogen Panel (xTAG GPP). This is the first clinical assay to be cleared on MAGPIX. xTAG GPP is the...
Benzinga  Mar 26  Comment 
Wedbush analyst Zarak Khurshid published a report on Luminex (NASDAQ: LMNX) that initiated coverage with a Neutral rating and $17.00 price target. In the report, Wedbush wrote, "We believe LMNX will continue to post top-line growth (up 8% in...
FierceBiotech  Mar 13  Comment 
Merck ($MRK) is pressing forward with its controversial Alzheimer's treatment, and now it has signed a deal with Luminex ($LMNX) to develop a companion diagnostic that will screen patients for its ongoing clinical program. The blockbuster hopeful...
StreetInsider.com  Feb 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Luminex+Corp+%28LMNX%29+Tops+Q4+EPS+by+1c/8056478.html for the full story.
StreetInsider.com  Jan 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Luminex+%28LMNX%29+Receives+FDA+Clearance+for+xTAG++GPP/8008337.html for the full story.
StreetInsider.com  Oct 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Luminex+Corp+%28LMNX%29+Misses+Q3+EPS+by+2c/7825675.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki